首页 > 最新文献

Journal of Microbiology Immunology and Infection最新文献

英文 中文
Complete response to front-line therapies is associated with long-term survival in HIV-related lymphomas in Taiwan 在台湾,对一线疗法的完全应答与艾滋病毒相关淋巴瘤患者的长期存活率有关
IF 7.4 2区 医学 Q2 IMMUNOLOGY Pub Date : 2024-06-01 DOI: 10.1016/j.jmii.2024.04.001
Wei-Li Ma , Wang-Da Liu , Hsin-Yun Sun , Wang-Huei Sheng , Szu-Min Hsieh , Shang-Ju Wu , Chien-Ching Hung

Background

The prognosis for people living with HIV (PLWH) who develop lymphomas has been greatly improved by combination antiretroviral therapy (cART) and anti-CD20 monoclonal antibodies. However, real-world clinical data on this patient group in Asia are limited.

Methods

Treatment outcomes were retrospectively examined for 104 PLWH with lymphomas between 2000 and 2019. The cohort comprised five PLWH with Hodgkin lymphoma (HL) and 99 with non-Hodgkin lymphomas, including 61 with diffuse large B-cell lymphoma (DLBCL), 19 with Burkitt lymphoma (BL), nine with primary central nervous system lymphoma (PCNSL) and ten with other subtypes.

Results

The 5-year overall survival (OS) rates were as follows: HL (100%), PCNSL (76.2%), other subtypes (60.0%), BL (57.4%), and DLBCL (55.6%). Individuals who achieved complete response (CR) to front-line therapies had a significantly better 5-year OS rate than those without (96.2% vs. 17.8%, p < 0.001). PLWH who received cART for ≤6 months had significantly lower CD4+ T-cell counts at lymphoma diagnosis than those who received cART for longer periods (p = 0.048). Additionally, the 5-year OS rate was better for PLWH who received cART for ≤6 months before lymphomas diagnosis than those who received cART for longer periods (64.5% vs. 51.9%, p = 0.114).

Conclusions

PLWH with DLBCL or BL had OS rates compatible to patients without HIV infection. Better outcomes for patients achieving CR to front-line therapy and those with shorter cART duration before lymphoma diagnosis suggest an underlying biological distinction in the lymphomas and the involvement of immunity, which warrants further studies.

抗逆转录病毒联合疗法(cART)和抗 CD20 单克隆抗体大大改善了罹患淋巴瘤的艾滋病病毒感染者(PLWH)的预后。然而,亚洲有关这一患者群体的实际临床数据却很有限。我们对2000年至2019年期间104名淋巴瘤患者的治疗结果进行了回顾性研究。其中包括5名霍奇金淋巴瘤(HL)患者和99名非霍奇金淋巴瘤患者,包括61名弥漫大B细胞淋巴瘤(DLBCL)患者、19名布基特淋巴瘤(BL)患者、9名原发性中枢神经系统淋巴瘤(PCNSL)患者和10名其他亚型淋巴瘤患者。5年总生存率(OS)如下:HL(100%)、PCNSL(76.2%)、其他亚型(60.0%)、BL(57.4%)和DLBCL(55.6%)。对一线疗法获得完全应答(CR)的患者的5年OS率明显高于未获得完全应答的患者(96.2% vs. 17.8%,P < 0.001)。接受 cART 治疗时间≤6 个月的 PLWH 在淋巴瘤确诊时的 CD4+ T 细胞计数明显低于接受 cART 治疗时间更长的 PLWH(= 0.048)。此外,淋巴瘤确诊前接受cART治疗时间≤6个月的感染者的5年OS率(64.5% vs. 51.9%,= 0.114)优于接受cART治疗时间更长的感染者。患有DLBCL或BL的PLWH的OS率与未感染HIV的患者相当。一线治疗达到CR的患者和淋巴瘤确诊前接受cART治疗时间较短的患者的预后较好,这表明淋巴瘤存在潜在的生物学差异和免疫参与,值得进一步研究。
{"title":"Complete response to front-line therapies is associated with long-term survival in HIV-related lymphomas in Taiwan","authors":"Wei-Li Ma ,&nbsp;Wang-Da Liu ,&nbsp;Hsin-Yun Sun ,&nbsp;Wang-Huei Sheng ,&nbsp;Szu-Min Hsieh ,&nbsp;Shang-Ju Wu ,&nbsp;Chien-Ching Hung","doi":"10.1016/j.jmii.2024.04.001","DOIUrl":"10.1016/j.jmii.2024.04.001","url":null,"abstract":"<div><h3>Background</h3><p>The prognosis for people living with HIV (PLWH) who develop lymphomas has been greatly improved by combination antiretroviral therapy (cART) and anti-CD20 monoclonal antibodies. However, real-world clinical data on this patient group in Asia are limited.</p></div><div><h3>Methods</h3><p>Treatment outcomes were retrospectively examined for 104 PLWH with lymphomas between 2000 and 2019. The cohort comprised five PLWH with Hodgkin lymphoma (HL) and 99 with non-Hodgkin lymphomas, including 61 with diffuse large B-cell lymphoma (DLBCL), 19 with Burkitt lymphoma (BL), nine with primary central nervous system lymphoma (PCNSL) and ten with other subtypes.</p></div><div><h3>Results</h3><p>The 5-year overall survival (OS) rates were as follows: HL (100%), PCNSL (76.2%), other subtypes (60.0%), BL (57.4%), and DLBCL (55.6%). Individuals who achieved complete response (CR) to front-line therapies had a significantly better 5-year OS rate than those without (96.2% vs. 17.8%, p &lt; 0.001). PLWH who received cART for ≤6 months had significantly lower CD4+ T-cell counts at lymphoma diagnosis than those who received cART for longer periods (<em>p</em> = 0.048). Additionally, the 5-year OS rate was better for PLWH who received cART for ≤6 months before lymphomas diagnosis than those who received cART for longer periods (64.5% vs. 51.9%, <em>p</em> = 0.114).</p></div><div><h3>Conclusions</h3><p>PLWH with DLBCL or BL had OS rates compatible to patients without HIV infection. Better outcomes for patients achieving CR to front-line therapy and those with shorter cART duration before lymphoma diagnosis suggest an underlying biological distinction in the lymphomas and the involvement of immunity, which warrants further studies.</p></div>","PeriodicalId":56117,"journal":{"name":"Journal of Microbiology Immunology and Infection","volume":"57 3","pages":"Pages 426-436"},"PeriodicalIF":7.4,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1684118224000707/pdfft?md5=bfcae08a560f15344eea91ee92ffb38d&pid=1-s2.0-S1684118224000707-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140584229","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Stool microbiota analysis for abundance of genus Klebsiella among adults and children in endemic area for community Klebsiella pneumoniae infection 社区肺炎克雷伯菌感染流行区成人和儿童粪便微生物群丰度分析
IF 7.4 2区 医学 Q2 IMMUNOLOGY Pub Date : 2024-06-01 DOI: 10.1016/j.jmii.2024.02.001
Chun-Hsing Liao , Kai-Liang Kao , Shu-I Wu , Chia-Jui Yang

Background

Invasive Klebsiella pneumoniae syndrome is a significant endemic disease in Taiwan. Intestinal colonization of virulent clones that cause this phenomenon has been demonstrated in asymptomatic adults. Comparisons of healthy adults and children with stool K. pneumoniae colonization have rarely been reported. We aimed to evaluate the frequency and abundance of K. pneumoniae in the stool of adults and children by stool microbiota analysis.

Methods

Healthy volunteers and their children without antibiotic exposure within 3 months were recruited in a Taiwanese medical center. Stool samples were sent for gut microbiota analysis, using amplification of V3–V4 hypervariable regions of 16sRNA followed by high-throughput sequence. Rectal/stool swabs were sent for K. pneumoniae culture and identification by matrix-assisted laser desorption ionization–time-of-flight mass spectrometry (MALDI-TOF MS).

Results

Fifty-five adults with a mean age of 46.9 years (range, 23.1–72.1 years) and 20 children with a mean age of 2.3 years (range, 0.9–5.8) were enrolled, and 29 adults and 6 children had positive K. pneumoniae swabs. Children had lower microbiota diversity than adults, including higher abundance of phylum Actinobacteria and Proteobacteria, and lower Bacteriodetes. For genus comparison, higher abundance of Escherichia, Streptococcus, Enterococcus and Bifidobacterium were found in children, but the composite abundance of Klebsiella in adults (median: 0.0156, range: 0–0.031) and in children (median: 0.0067, range: 0–0.043) were similar. Klebsiella abundance was significantly higher in participants with positive swabs (p < 0.0001). Klebsiella-positive swabs were strongly negatively correlated with Enterobacter spp. (p < 0.0001), but no known demographic factors correlated with Klebsiella-positive swabs.

Conclusion

Klebsiella species are present in young children, and the abundance is similar in adults and children. Positive swabs correlate strongly with higher abundance in microbiota analysis.

侵袭综合征是台湾的一种重要地方病。在无症状的成年人肠道中,已经证实了导致这种现象的毒性克隆的定植。对健康成人和儿童的粪便定植情况进行比较的报道很少。我们的目的是通过粪便微生物群分析来评估成人和儿童粪便中微生物的频率和丰度。我们在台湾一家医疗中心招募了 3 个月内未接触过抗生素的健康志愿者及其子女。粪便样本被送去进行肠道微生物群分析,方法是扩增 16sRNA 的 V3-V4 超变异区,然后进行高通量测序。直肠/凳子拭子样本被送去进行培养,并通过基质辅助激光解吸电离飞行时间质谱(MALDI-TOF MS)进行鉴定。55 名成人的平均年龄为 46.9 岁(范围在 23.1-72.1 岁之间),20 名儿童的平均年龄为 2.3 岁(范围在 0.9-5.8 岁之间)。与成人相比,儿童的微生物群多样性较低,包括较高的门类和Ⅳ类丰度以及较低的Ⅴ类丰度。在菌属比较中,儿童的 、 和 的丰度较高,但成人(中位数:0.0156,范围:0-0.031)和儿童(中位数:0.0067,范围:0-0.043)的综合丰度相似。0001)。阳性拭子与寄生虫属呈强烈负相关(p<0.0001),但没有已知的人口统计学因素与阳性拭子相关。在微生物群分析中,阳性拭子与较高的丰度密切相关。
{"title":"Stool microbiota analysis for abundance of genus Klebsiella among adults and children in endemic area for community Klebsiella pneumoniae infection","authors":"Chun-Hsing Liao ,&nbsp;Kai-Liang Kao ,&nbsp;Shu-I Wu ,&nbsp;Chia-Jui Yang","doi":"10.1016/j.jmii.2024.02.001","DOIUrl":"10.1016/j.jmii.2024.02.001","url":null,"abstract":"<div><h3>Background</h3><p>Invasive <em>Klebsiella pneumoniae</em> syndrome is a significant endemic disease in Taiwan. Intestinal colonization of virulent clones that cause this phenomenon has been demonstrated in asymptomatic adults. Comparisons of healthy adults and children with stool <em>K. pneumoniae</em> colonization have rarely been reported. We aimed to evaluate the frequency and abundance of <em>K. pneumoniae</em> in the stool of adults and children by stool microbiota analysis.</p></div><div><h3>Methods</h3><p>Healthy volunteers and their children without antibiotic exposure within 3 months were recruited in a Taiwanese medical center. Stool samples were sent for gut microbiota analysis, using amplification of V3–V4 hypervariable regions of 16sRNA followed by high-throughput sequence. Rectal/stool swabs were sent for <em>K. pneumoniae</em> culture and identification by matrix-assisted laser desorption ionization–time-of-flight mass spectrometry (MALDI-TOF MS).</p></div><div><h3>Results</h3><p>Fifty-five adults with a mean age of 46.9 years (range, 23.1–72.1 years) and 20 children with a mean age of 2.3 years (range, 0.9–5.8) were enrolled, and 29 adults and 6 children had positive <em>K. pneumoniae</em> swabs. Children had lower microbiota diversity than adults, including higher abundance of phylum <em>Actinobacteria</em> and <em>Proteobacteria</em>, and lower <em>Bacteriodetes</em>. For genus comparison, higher abundance of <em>Escherichia</em>, <em>Streptococcus, Enterococcus</em> and <em>Bifidobacterium</em> were found in children, but the composite abundance of <em>Klebsiella</em> in adults (median: 0.0156, range: 0–0.031) and in children (median: 0.0067, range: 0–0.043) were similar. <em>Klebsiella</em> abundance was significantly higher in participants with positive swabs (p &lt; 0.0001). <em>Klebsiella-</em>positive swabs were strongly negatively correlated with <em>Enterobacter</em> spp. (p &lt; 0.0001), but no known demographic factors correlated with <em>Klebsiella</em>-positive swabs.</p></div><div><h3>Conclusion</h3><p><em>Klebsiella</em> species are present in young children, and the abundance is similar in adults and children. Positive swabs correlate strongly with higher abundance in microbiota analysis.</p></div>","PeriodicalId":56117,"journal":{"name":"Journal of Microbiology Immunology and Infection","volume":"57 3","pages":"Pages 470-479"},"PeriodicalIF":7.4,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1684118224000380/pdfft?md5=f4fdd732a89b1c5f4c57be5f810f9fb7&pid=1-s2.0-S1684118224000380-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139919382","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Molnupiravir for the treatment of COVID-19 outpatients: An updated meta-analysis 用于治疗COVID-19门诊患者的莫诺吡韦:最新荟萃分析
IF 7.4 2区 医学 Q2 IMMUNOLOGY Pub Date : 2024-06-01 DOI: 10.1016/j.jmii.2024.03.002
Huzaifa Ahmad Cheema , Saleha Abdul Rab , Momina Butt , Uzair Jafar , Abia Shahid , Aqeeb Ur Rehman , Ka Yiu Lee , Syeda Sahra , Ranjit Sah

Background

The majority of available data on molnupiravir come from an unvaccinated COVID-19 population. Therefore, we conducted this meta-analysis to integrate evidence from recent randomized controlled trials (RCTs) as well as observational studies stratified by vaccination status to determine the clinical efficacy and safety of molnupiravir in COVID-19 outpatients.

Methods

We searched PubMed, Embase, the Cochrane Library, medRxiv, and ClinicalTrials.gov from inception to November 2023. We conducted our meta-analysis using RevMan 5.4 with risk ratio (RR) as the effect measure.

Results

We included 8 RCTs and 5 observational studies in our meta-analysis. Molnupiravir reduced the risk of all-cause mortality (RR 0.28; 95% CI: 0.20–0.79, I2 = 0%) but did not decrease the hospitalization rate (RR 0.67; 95% CI: 0.45–1.00, I2 = 53%) in the overall population; in the immunized population, no benefits were observed. Molnupiravir lowered the rate of no recovery (RR 0.78; 95% CI: 0.76–0.81, I2 = 0%) and increased virological clearance at day 5 (RR 2.68; 95% CI: 1.94–4.22, I2 = 85%). There was no increase in the incidence of adverse events.

Conclusions

Molnupiravir does not decrease mortality and hospitalization rates in immunized patients with COVID-19. However, it does shorten the disease course and increases the recovery rate. The use of molnupiravir will need to be considered on a case-by-case basis in the context of the prevailing social circumstances, the resource setting, drug costs, and the healthcare burden.

关于莫仑拉韦的大部分现有数据都来自未接种疫苗的 COVID-19 群体。因此,我们进行了这项荟萃分析,以整合近期随机对照试验 (RCT) 以及按疫苗接种情况分层的观察性研究的证据,从而确定莫仑匹拉韦对 COVID-19 门诊患者的临床疗效和安全性。我们检索了从开始到 2023 年 11 月的 PubMed、Embase、Cochrane 图书馆、medRxiv 和 ClinicalTrials.gov。我们使用 RevMan 5.4 进行了荟萃分析,并将风险比 (RR) 作为效果测量指标。我们在荟萃分析中纳入了 8 项研究性临床试验和 5 项观察性研究。在总体人群中,莫能吡韦降低了全因死亡风险(RR 0.28;95% CI:0.20-0.79,I= 0%),但没有降低住院率(RR 0.67;95% CI:0.45-1.00,I= 53%);在免疫人群中,没有观察到任何益处。莫能吡韦降低了无康复率(RR 0.78;95% CI:0.76-0.81,I= 0%),提高了第 5 天的病毒清除率(RR 2.68;95% CI:1.94-4.22,I= 85%)。不良事件的发生率没有增加。莫仑匹韦不会降低COVID-19免疫患者的死亡率和住院率。不过,它确实缩短了病程,提高了康复率。在使用莫仑匹拉韦时,需要根据当时的社会环境、资源环境、药物成本和医疗负担等因素逐一考虑。
{"title":"Molnupiravir for the treatment of COVID-19 outpatients: An updated meta-analysis","authors":"Huzaifa Ahmad Cheema ,&nbsp;Saleha Abdul Rab ,&nbsp;Momina Butt ,&nbsp;Uzair Jafar ,&nbsp;Abia Shahid ,&nbsp;Aqeeb Ur Rehman ,&nbsp;Ka Yiu Lee ,&nbsp;Syeda Sahra ,&nbsp;Ranjit Sah","doi":"10.1016/j.jmii.2024.03.002","DOIUrl":"10.1016/j.jmii.2024.03.002","url":null,"abstract":"<div><h3>Background</h3><p>The majority of available data on molnupiravir come from an unvaccinated COVID-19 population. Therefore, we conducted this meta-analysis to integrate evidence from recent randomized controlled trials (RCTs) as well as observational studies stratified by vaccination status to determine the clinical efficacy and safety of molnupiravir in COVID-19 outpatients.</p></div><div><h3>Methods</h3><p>We searched PubMed, Embase, the Cochrane Library, medRxiv, and ClinicalTrials.gov from inception to November 2023. We conducted our meta-analysis using RevMan 5.4 with risk ratio (RR) as the effect measure.</p></div><div><h3>Results</h3><p>We included 8 RCTs and 5 observational studies in our meta-analysis. Molnupiravir reduced the risk of all-cause mortality (RR 0.28; 95% CI: 0.20–0.79, I<sup>2</sup> = 0%) but did not decrease the hospitalization rate (RR 0.67; 95% CI: 0.45–1.00, I<sup>2</sup> = 53%) in the overall population; in the immunized population, no benefits were observed. Molnupiravir lowered the rate of no recovery (RR 0.78; 95% CI: 0.76–0.81, I<sup>2</sup> = 0%) and increased virological clearance at day 5 (RR 2.68; 95% CI: 1.94–4.22, I<sup>2</sup> = 85%). There was no increase in the incidence of adverse events.</p></div><div><h3>Conclusions</h3><p>Molnupiravir does not decrease mortality and hospitalization rates in immunized patients with COVID-19. However, it does shorten the disease course and increases the recovery rate. The use of molnupiravir will need to be considered on a case-by-case basis in the context of the prevailing social circumstances, the resource setting, drug costs, and the healthcare burden.</p></div>","PeriodicalId":56117,"journal":{"name":"Journal of Microbiology Immunology and Infection","volume":"57 3","pages":"Pages 396-402"},"PeriodicalIF":7.4,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1684118224000483/pdfft?md5=4b6955650f5b9b2cd94342d06166bf4f&pid=1-s2.0-S1684118224000483-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140151238","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Physical Activity and the incidence of sepsis: A 10-year observational study among 4 million adults 体育锻炼与败血症发病率:对 400 万成年人进行的一项为期 10 年的观察研究
IF 7.4 2区 医学 Q2 IMMUNOLOGY Pub Date : 2024-06-01 DOI: 10.1016/j.jmii.2024.04.009
Kyoung Hwa Lee , Eun Hwa Lee , Kyu-na Lee , Yebin Park , Young Goo Song , Kyung Do Han , Sang Hoon Han

Background

As the group at high risk for sepsis is increasing with the aging of the population, physical activity (PA), which has beneficial effects on various diseases, needs to be considered as a personalized prevention strategy for sepsis without direct anti-sepsis drug.

Purpose

To examine the association between the amount of PA (based on intensity, duration, and frequency) and the incidence rates of sepsis and mortality after sepsis.

Methods

This was a large-scale, retrospective, longitudinal cohort study using data from the Korean National Health Insurance Service and the biennial general health screening program. The amount of PA self-reported at the time of the health screening was categorized as non-PA, mild (<500 metabolic equivalents [METs]-Min/Week), moderate (500–1000), severe (1000–1500), and extreme (≥1500). The multivariable regression model was adjusted for age, sex, income, body mass index, smoking, alcohol consumption, diabetes, hypertension, dyslipidemia, and chronic diseases.

Results

From 4,234,415 individuals who underwent a health screening in 2009, 3,929,165 subjects were selected after exclusion for wash-out period and a 1-year lag period, and then observed for the event of sepsis or all-cause death until December 2020. During a median 10.3 years of follow-up, 83,011 incidents of sepsis were detected. The moderate-PA group showed the lowest incidence (1.56/1000 person-years) and risk for sepsis, with an adjusted hazard ratio (aHR) of 0.73 (95% CI, 0.72–0.75, P < 0.001) compared with the non-PA group. The occurrence of sepsis among people aged ≥65 years and ex-smokers were significantly lower in the moderate-PA group (aHR; 0.77, 95% CI; 0.74–0.79; and 0.68, 0.64–0.71, respectively, Ps < 0.001). The long-term all-cause mortality after sepsis was significantly lower in the PA group than in the non-PA group (overall P = 0.003).

Conclusions

Physical activity is associated with a lower risk of sepsis, especially in elderly people who have the highest incidence of sepsis. The protective effects of aerobic PA on sepsis might need to be incorporated with other interventions in sepsis guidelines through the accumulation of future studies.

随着人口老龄化的加剧,脓毒症的高危人群也在不断增加,而体力活动(PA)对多种疾病都有益处,因此有必要在不直接使用抗脓毒症药物的情况下,将体力活动作为一种个性化的脓毒症预防策略。目的:研究体力活动量(基于强度、持续时间和频率)与败血症发病率及败血症后死亡率之间的关系。这是一项大规模、回顾性、纵向队列研究,使用的数据来自韩国国民健康保险服务和两年一次的一般健康检查项目。健康检查时自我报告的 PA 量分为非 PA、轻度(<500 代谢当量 [METs]-分钟/周)、中度(500-1000)、重度(1000-1500)和极度(≥1500)。多变量回归模型对年龄、性别、收入、体重指数、吸烟、饮酒、糖尿病、高血压、血脂异常和慢性疾病进行了调整。从 2009 年接受健康检查的 4,234,415 人中,在排除冲洗期和 1 年滞后期后,选取了 3,929,165 名受试者,然后观察败血症或全因死亡事件,直至 2020 年 12 月。在中位 10.3 年的随访期间,共发现 83011 例败血症。与非PA组相比,中度PA组的败血症发生率(1.56/1000人-年)和风险最低,调整后危险比(aHR)为0.73(95% CI,0.72-0.75,<0.001)。在中度PA组中,年龄≥65岁者和曾吸烟者的败血症发生率明显较低(aHR;分别为0.77,95% CI;0.74-0.79;0.68,0.64-0.71,s <0.001)。脓毒症后的长期全因死亡率,体育锻炼组明显低于非体育锻炼组(总体 = 0.003)。体育锻炼与降低败血症风险有关,尤其是对败血症发病率最高的老年人而言。有氧体育锻炼对败血症的保护作用可能需要通过未来研究的积累与其他干预措施一起纳入败血症指南。
{"title":"Physical Activity and the incidence of sepsis: A 10-year observational study among 4 million adults","authors":"Kyoung Hwa Lee ,&nbsp;Eun Hwa Lee ,&nbsp;Kyu-na Lee ,&nbsp;Yebin Park ,&nbsp;Young Goo Song ,&nbsp;Kyung Do Han ,&nbsp;Sang Hoon Han","doi":"10.1016/j.jmii.2024.04.009","DOIUrl":"10.1016/j.jmii.2024.04.009","url":null,"abstract":"<div><h3>Background</h3><p>As the group at high risk for sepsis is increasing with the aging of the population, physical activity (PA), which has beneficial effects on various diseases, needs to be considered as a personalized prevention strategy for sepsis without direct anti-sepsis drug.</p></div><div><h3>Purpose</h3><p>To examine the association between the amount of PA (based on intensity, duration, and frequency) and the incidence rates of sepsis and mortality after sepsis.</p></div><div><h3>Methods</h3><p>This was a large-scale, retrospective, longitudinal cohort study using data from the Korean National Health Insurance Service and the biennial general health screening program. The amount of PA self-reported at the time of the health screening was categorized as non-PA, mild (&lt;500 metabolic equivalents [METs]-Min/Week), moderate (500–1000), severe (1000–1500), and extreme (≥1500). The multivariable regression model was adjusted for age, sex, income, body mass index, smoking, alcohol consumption, diabetes, hypertension, dyslipidemia, and chronic diseases.</p></div><div><h3>Results</h3><p>From 4,234,415 individuals who underwent a health screening in 2009, 3,929,165 subjects were selected after exclusion for wash-out period and a 1-year lag period, and then observed for the event of sepsis or all-cause death until December 2020. During a median 10.3 years of follow-up, 83,011 incidents of sepsis were detected. The moderate-PA group showed the lowest incidence (1.56/1000 person-years) and risk for sepsis, with an adjusted hazard ratio (aHR) of 0.73 (95% CI, 0.72–0.75, <em>P</em> &lt; 0.001) compared with the non-PA group. The occurrence of sepsis among people aged ≥65 years and ex-smokers were significantly lower in the moderate-PA group (aHR; 0.77, 95% CI; 0.74–0.79; and 0.68, 0.64–0.71, respectively, <em>P</em>s &lt; 0.001). The long-term all-cause mortality after sepsis was significantly lower in the PA group than in the non-PA group (overall <em>P</em> = 0.003).</p></div><div><h3>Conclusions</h3><p>Physical activity is associated with a lower risk of sepsis, especially in elderly people who have the highest incidence of sepsis. The protective effects of aerobic PA on sepsis might need to be incorporated with other interventions in sepsis guidelines through the accumulation of future studies.</p></div>","PeriodicalId":56117,"journal":{"name":"Journal of Microbiology Immunology and Infection","volume":"57 3","pages":"Pages 354-364"},"PeriodicalIF":7.4,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S168411822400077X/pdfft?md5=323572f5921902f73e5598c4686e4ef4&pid=1-s2.0-S168411822400077X-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140812139","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
ddPCR enables rapid detection of bloodstream infections in patients on home parenteral nutrition: A prospective cohort study ddPCR 可快速检测接受家庭父母营养的患者的血流感染:一项前瞻性队列研究
IF 7.4 2区 医学 Q2 IMMUNOLOGY Pub Date : 2024-06-01 DOI: 10.1016/j.jmii.2024.03.003
Veerle E.L.M. Gillis , Daisy Dalloyaux , Rene H.M. te Morsche , Jakko van Ingen , Özcan Sir , Chantal P. Rovers , Yannick Wouters , Geert J.A. Wanten

Introduction

Chronic intestinal failure patients (CIF) require a central venous access device (CVAD) to administer parenteral nutrition. Most serious complication related to a CVAD is a central line-associated bloodstream infection (CLABSI). The golden standard to diagnose a CLABSI are blood cultures, however, they may require 1–5 days before getting a result. Droplet digital polymerase chain reaction (ddPCR) for the detection of pathogen 16S/28S rRNA is a novel culture-independent molecular technique that has been developed to enhance and expedite infection diagnostics within two and a half hours. In this study, we prospectively compared ddPCR with blood cultures to detect pathogens in whole blood.

Methods

We included adult CIF patients with a clinical suspicion of CLABSI in this prospective single-blinded clinical study. Blood cultures were routinely collected and subsequently two central samples from the CVAD and two peripheral samples from a peripheral venous access point. Primary outcome was the sensitivity and specificity of ddPCR.

Results

In total, 75 patients with 126 suspected CLABSI episodes were included, with 80 blood samples from the CVAD and 114 from peripheral veins. The central ddPCR samples showed a sensitivity of 91% (95%CI 77–98), and specificity of 96% (95%CI 85–99). Peripheral ddPCR samples had a sensitivity of 63% (95%CI 46–77) and specificity of 99% (95%CI 93–100).

Conclusion

ddPCR showed a high sensitivity and specificity relative to blood cultures and enables rapid pathogen detection and characterization. Clinical studies should explore if integrated ddPCR and blood culture outcomes enables a more rapid pathogen guided CLABSI treatment and enhancing patient outcomes.

导言慢性肠功能衰竭患者(CIF)需要使用中心静脉通路装置(CVAD)来进行肠外营养。与 CVAD 相关的最严重并发症是中心静脉相关血流感染(CLABSI)。诊断 CLABSI 的黄金标准是血液培养,但可能需要 1-5 天才能得出结果。用于检测病原体 16S/28S rRNA 的液滴数字聚合酶链反应(ddPCR)是一种新型的独立于培养的分子技术,它的开发可在两个半小时内提高和加快感染诊断的速度。在这项研究中,我们对 ddPCR 和血液培养检测全血中病原体的方法进行了前瞻性比较。常规采集血液培养物,随后采集两份来自 CVAD 的中心样本和两份来自外周静脉接入点的外周样本。主要结果是 ddPCR 的灵敏度和特异性。结果共纳入了 75 名疑似 CLABSI 患者,共 126 例,其中 80 例血液样本来自 CVAD,114 例来自外周静脉。中心 ddPCR 样本的灵敏度为 91%(95%CI 77-98),特异性为 96%(95%CI 85-99)。外周 ddPCR 样本的灵敏度为 63%(95%CI 46-77),特异性为 99%(95%CI 93-100)。临床研究应探讨综合 ddPCR 和血液培养结果是否能更快速地在病原体指导下进行 CLABSI 治疗,并提高患者的治疗效果。
{"title":"ddPCR enables rapid detection of bloodstream infections in patients on home parenteral nutrition: A prospective cohort study","authors":"Veerle E.L.M. Gillis ,&nbsp;Daisy Dalloyaux ,&nbsp;Rene H.M. te Morsche ,&nbsp;Jakko van Ingen ,&nbsp;Özcan Sir ,&nbsp;Chantal P. Rovers ,&nbsp;Yannick Wouters ,&nbsp;Geert J.A. Wanten","doi":"10.1016/j.jmii.2024.03.003","DOIUrl":"10.1016/j.jmii.2024.03.003","url":null,"abstract":"<div><h3>Introduction</h3><p>Chronic intestinal failure patients (CIF) require a central venous access device (CVAD) to administer parenteral nutrition. Most serious complication related to a CVAD is a central line-associated bloodstream infection (CLABSI). The golden standard to diagnose a CLABSI are blood cultures, however, they may require 1–5 days before getting a result. Droplet digital polymerase chain reaction (ddPCR) for the detection of pathogen 16S/28S rRNA is a novel culture-independent molecular technique that has been developed to enhance and expedite infection diagnostics within two and a half hours. In this study, we prospectively compared ddPCR with blood cultures to detect pathogens in whole blood.</p></div><div><h3>Methods</h3><p>We included adult CIF patients with a clinical suspicion of CLABSI in this prospective single-blinded clinical study. Blood cultures were routinely collected and subsequently two central samples from the CVAD and two peripheral samples from a peripheral venous access point. Primary outcome was the sensitivity and specificity of ddPCR.</p></div><div><h3>Results</h3><p>In total, 75 patients with 126 suspected CLABSI episodes were included, with 80 blood samples from the CVAD and 114 from peripheral veins. The central ddPCR samples showed a sensitivity of 91% (95%CI 77–98), and specificity of 96% (95%CI 85–99). Peripheral ddPCR samples had a sensitivity of 63% (95%CI 46–77) and specificity of 99% (95%CI 93–100).</p></div><div><h3>Conclusion</h3><p>ddPCR showed a high sensitivity and specificity relative to blood cultures and enables rapid pathogen detection and characterization. Clinical studies should explore if integrated ddPCR and blood culture outcomes enables a more rapid pathogen guided CLABSI treatment and enhancing patient outcomes.</p></div>","PeriodicalId":56117,"journal":{"name":"Journal of Microbiology Immunology and Infection","volume":"57 3","pages":"Pages 375-384"},"PeriodicalIF":7.4,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1684118224000495/pdfft?md5=bb494a380ddd49fe7d64903a92774782&pid=1-s2.0-S1684118224000495-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140278755","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Intestinal capillariasis: An indigenous case in Taiwan 肠毛滴虫病:台湾的一个本土病例
IF 7.4 2区 医学 Q2 IMMUNOLOGY Pub Date : 2024-06-01 DOI: 10.1016/j.jmii.2024.04.007
Wei-Te Lee, Chih-Lin Huang, Rong-Jyh Lin, Chao-Ju Chen, Kuan-Li Wu, June-Der Lee, Yue-Chiu Su
{"title":"Intestinal capillariasis: An indigenous case in Taiwan","authors":"Wei-Te Lee,&nbsp;Chih-Lin Huang,&nbsp;Rong-Jyh Lin,&nbsp;Chao-Ju Chen,&nbsp;Kuan-Li Wu,&nbsp;June-Der Lee,&nbsp;Yue-Chiu Su","doi":"10.1016/j.jmii.2024.04.007","DOIUrl":"10.1016/j.jmii.2024.04.007","url":null,"abstract":"","PeriodicalId":56117,"journal":{"name":"Journal of Microbiology Immunology and Infection","volume":"57 3","pages":"Pages 520-522"},"PeriodicalIF":7.4,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1684118224000756/pdfft?md5=f4859888ce83d05350bc08e0c1306147&pid=1-s2.0-S1684118224000756-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140765597","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Combination of trimethoprim-sulfamethoxazole and clindamycin in the treatment of relapsing toxoplasmic encephalitis 三甲双胍-磺胺甲噁唑和克林霉素联合治疗复发性弓形虫脑炎。
IF 7.4 2区 医学 Q2 IMMUNOLOGY Pub Date : 2024-06-01 DOI: 10.1016/j.jmii.2024.02.008
Shih-Wen Ting, Jien-Wei Liu
{"title":"Combination of trimethoprim-sulfamethoxazole and clindamycin in the treatment of relapsing toxoplasmic encephalitis","authors":"Shih-Wen Ting,&nbsp;Jien-Wei Liu","doi":"10.1016/j.jmii.2024.02.008","DOIUrl":"10.1016/j.jmii.2024.02.008","url":null,"abstract":"","PeriodicalId":56117,"journal":{"name":"Journal of Microbiology Immunology and Infection","volume":"57 3","pages":"Pages 518-519"},"PeriodicalIF":7.4,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1684118224000458/pdfft?md5=75af8bbc49ac367feb65c2f6de89046b&pid=1-s2.0-S1684118224000458-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140040998","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Revisiting the association between vitamin D deficiency and active tuberculosis: A prospective case-control study in Taiwan 重新审视维生素 D 缺乏与活动性肺结核之间的关系:台湾的一项前瞻性病例对照研究
IF 7.4 2区 医学 Q2 IMMUNOLOGY Pub Date : 2024-06-01 DOI: 10.1016/j.jmii.2024.03.005
Meng-Shiuan Hsu , Tzu-Chien Chung , Ping-Huai Wang , Shih-Lung Cheng , Yen-Wen Wu , Jung-Cheng Hsu , Bing-Hsiean Tzeng , Heng-Hsu Lin , Chung-Ming Tu , Fang-Yeh Chu , Chi-Tai Fang

Background

To revisit the association between vitamin D deficiency (VDD, defined as serum 25(OH)D < 20 ng/ml) and incident active tuberculosis (TB), after two potentially underpowered randomized trials showed statistically non-significant 13%–22% decrease in TB incidence in vitamin D supplementation groups.

Methods

We prospectively conducted an age/sex-matched case–control study that accounting for body-mass index (BMI), smoking, and other confounding factors to examine the association between VDD and active TB among non-HIV people in Taiwan (latitude 24°N), a high-income society which continues to have moderate TB burden.

Results

We enrolled 62 people with incident active TB and 248 people in control group. The TB case patients had a significantly higher proportion of VDD compared to the control group (51.6% vs 29.8%, p = 0.001). The 25(OH)D level was also significantly lower in TB patients compared to control group (21.25 ± 8.93 ng/ml vs 24.45 ± 8.36 ng/ml, p = 0.008). In multivariable analysis, VDD (adjusted odds ratio [aOR]: 3.03, p = 0.002), lower BMI (aOR: 0.81, p < 0.001), liver cirrhosis (aOR: 8.99, p = 0.042), and smoking (aOR: 4.52, p = 0.001) were independent risk factors for incident active TB.

Conclusions

VDD is an independent risk factor for incident active TB. Future randomized trials examining the effect of vitamin D supplementation on TB incidence should focus on people with a low BMI or other risk factors to maximize the statistical power.

背景为了重新研究维生素 D 缺乏症(VDD,定义为血清 25(OH)D < 20 ng/ml)与活动性肺结核(TB)发病率之间的关系,此前有两项可能效力不足的随机试验显示,维生素 D 补充组的肺结核发病率在统计学上无明显下降,降幅为 13%-22% 。我们在台湾(北纬 24°)开展了一项年龄/性别匹配的病例对照研究,在考虑体重指数(BMI)、吸烟和其他混杂因素的情况下,研究了维生素 D 与非艾滋病毒感染者中活动性肺结核之间的关系。与对照组相比,肺结核病例患者的 VDD 比例明显更高(51.6% 对 29.8%,P = 0.001)。结核病患者的 25(OH)D 水平也明显低于对照组(21.25 ± 8.93 ng/ml vs 24.45 ± 8.36 ng/ml,p = 0.008)。在多变量分析中,VDD(调整赔率[aOR]:3.03,p = 0.002)、较低体重指数(aOR:0.81,p < 0.001)、肝硬化(aOR:8.99,p = 0.042)和吸烟(aOR:4.52,p = 0.001)是发生活动性肺结核的独立危险因素。未来研究维生素 D 补充剂对结核病发病率影响的随机试验应侧重于体重指数较低或有其他风险因素的人群,以最大限度地提高统计能力。
{"title":"Revisiting the association between vitamin D deficiency and active tuberculosis: A prospective case-control study in Taiwan","authors":"Meng-Shiuan Hsu ,&nbsp;Tzu-Chien Chung ,&nbsp;Ping-Huai Wang ,&nbsp;Shih-Lung Cheng ,&nbsp;Yen-Wen Wu ,&nbsp;Jung-Cheng Hsu ,&nbsp;Bing-Hsiean Tzeng ,&nbsp;Heng-Hsu Lin ,&nbsp;Chung-Ming Tu ,&nbsp;Fang-Yeh Chu ,&nbsp;Chi-Tai Fang","doi":"10.1016/j.jmii.2024.03.005","DOIUrl":"10.1016/j.jmii.2024.03.005","url":null,"abstract":"<div><h3>Background</h3><p>To revisit the association between vitamin D deficiency (VDD, defined as serum 25(OH)D &lt; 20 ng/ml) and incident active tuberculosis (TB), after two potentially underpowered randomized trials showed statistically non-significant 13%–22% decrease in TB incidence in vitamin D supplementation groups.</p></div><div><h3>Methods</h3><p>We prospectively conducted an age/sex-matched case–control study that accounting for body-mass index (BMI), smoking, and other confounding factors to examine the association between VDD and active TB among non-HIV people in Taiwan (latitude 24°N), a high-income society which continues to have moderate TB burden.</p></div><div><h3>Results</h3><p>We enrolled 62 people with incident active TB and 248 people in control group. The TB case patients had a significantly higher proportion of VDD compared to the control group (51.6% vs 29.8%, <em>p</em> = 0.001). The 25(OH)D level was also significantly lower in TB patients compared to control group (21.25 ± 8.93 ng/ml vs 24.45 ± 8.36 ng/ml, <em>p</em> = 0.008). In multivariable analysis, VDD (adjusted odds ratio [aOR]: 3.03, <em>p</em> = 0.002), lower BMI (aOR: 0.81, <em>p</em> &lt; 0.001), liver cirrhosis (aOR: 8.99, <em>p</em> = 0.042), and smoking (aOR: 4.52, <em>p</em> = 0.001) were independent risk factors for incident active TB.</p></div><div><h3>Conclusions</h3><p>VDD is an independent risk factor for incident active TB. Future randomized trials examining the effect of vitamin D supplementation on TB incidence should focus on people with a low BMI or other risk factors to maximize the statistical power.</p></div>","PeriodicalId":56117,"journal":{"name":"Journal of Microbiology Immunology and Infection","volume":"57 3","pages":"Pages 490-497"},"PeriodicalIF":7.4,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1684118224000689/pdfft?md5=ed5b48cc6f1590009f8468b243daf469&pid=1-s2.0-S1684118224000689-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140402537","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Influenza and the risk of active tuberculosis occurrence among individuals with latent tuberculosis infection: A national cohort study in South Korea (2015–2020) 流感与潜伏肺结核感染者发生活动性肺结核的风险:韩国全国队列研究(2015-2020 年)
IF 7.4 2区 医学 Q2 IMMUNOLOGY Pub Date : 2024-06-01 DOI: 10.1016/j.jmii.2024.04.003
Jaehee Lee , Hyewon Seo , Dohyang Kim , Jinseub Hwang , Jin-Won Kwon

Background

Influenza's potential impact on active tuberculosis (TB) development has been debated, with limited clinical evidence. To address this, we explored the association between influenza episodes and TB incidence in a national cohort of individuals with latent TB infection (LTBI).

Methods

We examined adults (≥20 years) diagnosed with LTBI between 2015 and 2020, using the Health Insurance Review and Assessment Service's national database in South Korea. We collected demographic data, comorbidities, and influenza episodes within 6 months before and after the initial LTBI diagnosis (prior vs. subsequent episode). We stratified the analysis into groups with and without TB preventive therapy (TPT).

Results

Among 220,483 LTBI subjects, 49% received TPT, while 51% did not. The average age was 48.4 years, with 52% having comorbidities. A prior and subsequent influenza episode was identified in 3221 and 4580 individuals, respectively. Of these, 1159 (0.53%) developed incident TB over an average follow-up of 1.86 years. The incidence rates of TB were comparable between individuals with and without prior and/or subsequent influenza episodes in the TPT group, but 1.4 times higher in the non-TPT group for those with such episodes. Cox proportional-hazards regression analysis indicated that influenza was not a risk factor for incident TB in the TPT group. However, a subsequent influenza episode significantly increased TB risk in the non-TPT group (hazard ratio: 1.648 [95% CI, 1.053–2.580]).

Conclusions

In individuals with LTBI not receiving TPT, experiencing an influenza episode may elevate the risk of developing active TB.

流感对活动性肺结核(TB)发展的潜在影响一直存在争议,临床证据有限。为了解决这个问题,我们在全国潜伏肺结核感染者(LTBI)队列中探讨了流感发作与肺结核发病率之间的关系。我们利用韩国健康保险审查和评估服务部的国家数据库,对 2015 年至 2020 年期间确诊为 LTBI 的成年人(≥20 岁)进行了调查。我们收集了人口统计学数据、合并症以及初次确诊 LTBI 前后 6 个月内的流感发病情况(前期发病与后续发病)。我们将分析分为接受和未接受结核病预防治疗(TPT)的两组。在 220,483 例 LTBI 受试者中,49% 接受了 TPT 治疗,51% 没有。受试者的平均年龄为 48.4 岁,52% 的人患有合并症。分别有 3221 人和 4580 人在之前和之后患过流感。其中,1159 人(0.53%)在平均 1.86 年的随访期间患上了结核病。在 TPT 组中,之前和/或之后患过流感和/或没有患过流感的人的肺结核发病率相当,但在非 TPT 组中,患过流感和/或没有患过流感的人的肺结核发病率是 TPT 组的 1.4 倍。Cox 比例危险回归分析表明,在 TPT 组中,流感并不是肺结核发病的风险因素。然而,在非 TPT 组中,随后的流感发作会显著增加结核病风险(危险比:1.648 [95% CI, 1.053-2.580])。对于未接受 TPT 治疗的 LTBI 患者来说,流感发作可能会增加罹患活动性肺结核的风险。
{"title":"Influenza and the risk of active tuberculosis occurrence among individuals with latent tuberculosis infection: A national cohort study in South Korea (2015–2020)","authors":"Jaehee Lee ,&nbsp;Hyewon Seo ,&nbsp;Dohyang Kim ,&nbsp;Jinseub Hwang ,&nbsp;Jin-Won Kwon","doi":"10.1016/j.jmii.2024.04.003","DOIUrl":"10.1016/j.jmii.2024.04.003","url":null,"abstract":"<div><h3>Background</h3><p>Influenza's potential impact on active tuberculosis (TB) development has been debated, with limited clinical evidence. To address this, we explored the association between influenza episodes and TB incidence in a national cohort of individuals with latent TB infection (LTBI).</p></div><div><h3>Methods</h3><p>We examined adults (≥20 years) diagnosed with LTBI between 2015 and 2020, using the Health Insurance Review and Assessment Service's national database in South Korea. We collected demographic data, comorbidities, and influenza episodes within 6 months before and after the initial LTBI diagnosis (prior vs. subsequent episode). We stratified the analysis into groups with and without TB preventive therapy (TPT).</p></div><div><h3>Results</h3><p>Among 220,483 LTBI subjects, 49% received TPT, while 51% did not. The average age was 48.4 years, with 52% having comorbidities. A prior and subsequent influenza episode was identified in 3221 and 4580 individuals, respectively. Of these, 1159 (0.53%) developed incident TB over an average follow-up of 1.86 years. The incidence rates of TB were comparable between individuals with and without prior and/or subsequent influenza episodes in the TPT group, but 1.4 times higher in the non-TPT group for those with such episodes. Cox proportional-hazards regression analysis indicated that influenza was not a risk factor for incident TB in the TPT group. However, a subsequent influenza episode significantly increased TB risk in the non-TPT group (hazard ratio: 1.648 [95% CI, 1.053–2.580]).</p></div><div><h3>Conclusions</h3><p>In individuals with LTBI not receiving TPT, experiencing an influenza episode may elevate the risk of developing active TB.</p></div>","PeriodicalId":56117,"journal":{"name":"Journal of Microbiology Immunology and Infection","volume":"57 3","pages":"Pages 437-445"},"PeriodicalIF":7.4,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1684118224000719/pdfft?md5=fc1877d020ae9a07b41ecbfe251fe6e2&pid=1-s2.0-S1684118224000719-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140584184","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
ProFun: A web server for functional enrichment analysis of parasitic protozoan genes ProFun:寄生原生动物基因功能富集分析网络服务器
IF 7.4 2区 医学 Q2 IMMUNOLOGY Pub Date : 2024-06-01 DOI: 10.1016/j.jmii.2024.01.007
Po-Jung Huang , Yi-Chen Weng , Kuo-Yang Huang , Chi-Ching Lee , Yuan-Ming Yeh , Yu-Tong Chen , Cheng-Hsun Chiu , Petrus Tang

Background

The initial step to interpreting putative biological functions from comparative multi-omics studies usually starts from a differential expressed gene list followed by functional enrichment analysis (FEA). However, most FEA packages are designed exclusively for humans and model organisms. Although parasitic protozoan is the most important pathogen in the tropics, no FEA package is available for protozoan functional (ProFun) enrichment analysis. To speed up comparative multi-omics research on parasitic protozoans, we constructed ProFun, a web-based, user-friendly platform for the research community.

Methods

ProFun utilizes the Docker container, ShinyProxy, and R Shiny to construct a scalable web service with load-balancing infrastructure. We have integrated a series of visual analytic functions, in-house scripts, and custom-made annotation packages to create three analytical modules for 40 protozoan species: (1) Gene Overlaps; (2) Over-representation Analysis (ORA); (3) Gene Set Enrichment Analysis (GSEA).

Results

We have established ProFun, a web server for functional enrichment analysis of differentially expressed genes. FEA becomes as simple as pasting a list of gene IDs into the textbox of our website. Users can customize enrichment parameters and results with just one click. The intuitive web interface and publication-ready charts enable users to reveal meaningful biological events and pinpoint potential targets for further studies.

Conclusion

ProFun is the first web application that enables gene functional enrichment analysis of parasitic protozoans. In addition to supporting FEA analysis, ProFun also allows the comparison of FEA results across complicated experimental designs. ProFun is freely available at http://dalek.cgu.edu.tw:8080/app/profun.

背景从比较多组学研究中解读推测生物功能的第一步通常是从差异表达基因列表开始,然后是功能富集分析(FEA)。然而,大多数功能富集分析软件包都是专为人类和模式生物设计的。虽然寄生原生动物是热带地区最重要的病原体,但目前还没有用于原生动物功能(ProFun)富集分析的 FEA 软件包。为了加快寄生原生动物的多组学比较研究,我们为研究界构建了一个基于网络、用户友好的平台--ProFun。方法ProFun利用Docker容器、ShinyProxy和R Shiny构建了一个具有负载平衡基础设施的可扩展网络服务。我们整合了一系列可视化分析功能、内部脚本和定制注释包,为40种原生动物创建了三个分析模块:(1)基因重叠;(2)过度呈现分析(ORA);(3)基因组富集分析(GSEA)。只需将基因 ID 列表粘贴到我们网站的文本框中,富集分析就变得非常简单。用户只需点击一下,就能定制富集参数和结果。直观的网络界面和可供发表的图表使用户能够揭示有意义的生物事件,并为进一步研究确定潜在的目标。除了支持有限元分析外,ProFun 还可以比较不同复杂实验设计的有限元分析结果。ProFun 可在 http://dalek.cgu.edu.tw:8080/app/profun 免费获取。
{"title":"ProFun: A web server for functional enrichment analysis of parasitic protozoan genes","authors":"Po-Jung Huang ,&nbsp;Yi-Chen Weng ,&nbsp;Kuo-Yang Huang ,&nbsp;Chi-Ching Lee ,&nbsp;Yuan-Ming Yeh ,&nbsp;Yu-Tong Chen ,&nbsp;Cheng-Hsun Chiu ,&nbsp;Petrus Tang","doi":"10.1016/j.jmii.2024.01.007","DOIUrl":"10.1016/j.jmii.2024.01.007","url":null,"abstract":"<div><h3>Background</h3><p>The initial step to interpreting putative biological functions from comparative multi-omics studies usually starts from a differential expressed gene list followed by functional enrichment analysis (FEA). However, most FEA packages are designed exclusively for humans and model organisms. Although parasitic protozoan is the most important pathogen in the tropics, no FEA package is available for protozoan functional (ProFun) enrichment analysis. To speed up comparative multi-omics research on parasitic protozoans, we constructed ProFun, a web-based, user-friendly platform for the research community.</p></div><div><h3>Methods</h3><p>ProFun utilizes the Docker container, ShinyProxy, and R Shiny to construct a scalable web service with load-balancing infrastructure. We have integrated a series of visual analytic functions, in-house scripts, and custom-made annotation packages to create three analytical modules for 40 protozoan species: (1) Gene Overlaps; (2) Over-representation Analysis (ORA); (3) Gene Set Enrichment Analysis (GSEA).</p></div><div><h3>Results</h3><p>We have established ProFun, a web server for functional enrichment analysis of differentially expressed genes. FEA becomes as simple as pasting a list of gene IDs into the textbox of our website. Users can customize enrichment parameters and results with just one click. The intuitive web interface and publication-ready charts enable users to reveal meaningful biological events and pinpoint potential targets for further studies.</p></div><div><h3>Conclusion</h3><p>ProFun is the first web application that enables gene functional enrichment analysis of parasitic protozoans. In addition to supporting FEA analysis, ProFun also allows the comparison of FEA results across complicated experimental designs. ProFun is freely available at <span>http://dalek.cgu.edu.tw:8080/app/profun</span><svg><path></path></svg>.</p></div>","PeriodicalId":56117,"journal":{"name":"Journal of Microbiology Immunology and Infection","volume":"57 3","pages":"Pages 509-517"},"PeriodicalIF":7.4,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1684118224000082/pdfft?md5=da2b1e7df910725f9a188a4ac4ea5200&pid=1-s2.0-S1684118224000082-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139679427","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Microbiology Immunology and Infection
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1